Eligibility, any sex, with Device Related Sepsis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Successful Administration of 60 mL/kgPrimary· 20 minutes
Participants will be timed to determine if they are able to administer 60 mL/kg of fluid within a 20 minute timeframe. This outcome will be measured as a dichotomous 'yes' or 'no' as to whether the task was completed successfully. The initial registered primary outcome was changed from 60 cc/kg in 15 minutes to its current format before the study began.
Group
Value
95% CI
Pressure Bag
14
Push/Pull
18
Lifeflow
16
Time to Complete Fluid AdministrationSecondary· Up to 20 minutes
Participants will be timed to determine if they are able to administer 60 mL/kg of fluid within a 20 minute timeframe. The time in which they complete the task will be captured in minutes. The initial registered primary outcome was changed from 60 cc/kg in 15 minutes to its current format before the study began.
Group
Value
95% CI
Pressure Bag
718.9
± 57.3
Push/Pull
519.4
± 26.3
Lifeflow
376.5
± 30.4
NASA Task Load Index (TLX)Secondary· 15 minutes
The NASA Task Load Index (TLX) is a series of measures that capture workload. Each scale employs a visual analog scale that measures each of the domains. The domains are Mental Domain, Physical Demand, Temporal Demand, Performance, Effort and Frustration Level. Each scale domain and the Composite has a range from 0 to 100 with 100 being the highest indicator of workload.
Composite
Group
Value
95% CI
Pressure Bag
42.50
22.08 – 54.79
Push/Pull
40.42
22.29 – 48.13
Lifeflow
30.00
22.08 – 38.33
Mental
Group
Value
95% CI
Pressure Bag
60.00
43.75 – 75.00
Push/Pull
57.50
31.25 – 68.78
Lifeflow
37.50
20.00 – 50.00
Physical
Group
Value
95% CI
Pressure Bag
20.00
5.00 – 57.50
Push/Pull
22.50
11.25 – 53.75
Lifeflow
20.00
5.00 – 50.00
Temporal
Group
Value
95% CI
Pressure Bag
55.00
30.00 – 71.25
Push/Pull
62.50
31.25 – 75.00
Lifeflow
35.00
23.75 – 51.25
Performance
Group
Value
95% CI
Pressure Bag
27.50
20.00 – 47.50
Push/Pull
22.50
10.00 – 37.50
Lifeflow
25.00
20.00 – 30.00
Effort
Group
Value
95% CI
Pressure Bag
57.50
30.00 – 75.00
Push/Pull
50.00
33.75 – 65.00
Lifeflow
40.00
20.00 – 56.25
Frustration
Group
Value
95% CI
Pressure Bag
15.00
5.00 – 40.00
Push/Pull
17.50
6.25 – 30.00
Lifeflow
12.50
5.00 – 17.50
Sponsor's own description
The aim of the study is to determine if a new device is more effective in fluid administration than devices currently used when resuscitating pediatric patients in septic shock. This study will take place in a simulation lab setting and will not include the use of patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking
· Phase 2
· not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing
· NA
· not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S
· NA
· not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa
· Phase 1, PHASE2
· not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 31 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03074682.